LDN193189 hydrochloride
LDN193189 is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM, displays >200-fold selectivity for BMP signaling over TGF-β signaling (IC50>1,000 nM) ; efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 (IC50=5 nM and 30 nM, respectively), with weaker effects on activin and the TGF-β type I receptors ALK4, ALK5 and ALK7; also blocks the transcriptional activity induced by either constitutively active ALK2 R206H or ALK2 Q207D mutant proteins, affects BMP-induced osteoblast differentiation, attenuates ectopic ossification in vivo.
Product Specifications
CAS Number
1062368-62-0
Product Name Alternative
LDN 193189 hydrochloride | LDN-193189 hydrochloride
Purity
>98% (HPLC)
Solubility
H2O: 20 mg/mL
Smiles
[H]Cl.C1 (C2=C3N=CC (C4=CC=C (N5CCNCC5) C=C4) =CN3N=C2) =CC=NC6=CC=CC=C16
Molecular Formula
C25H26Cl4N6
Molecular Weight
552.3261
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Quinoline, 4-[6-[4- (1-piperazinyl) phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-, hydrochloride (1:1)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog